Pulse lineResearch With Heart Logo

Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study.

TitleObesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study.
Publication TypeJournal Article
Year of Publication2021
AuthorsRaffield LM, Howard AGreen, Graff M, Lin D-Y, Cheng S, Demerath E, Ndumele C, Palta P, Rebholz CM, Seidelmann S, Yu B, Gordon-Larsen P, North KE, Avery CL
JournalJ Am Heart Assoc
Volume10
Issue24
Paginatione019946
Date Published2021 12 21
ISSN2047-9980
KeywordsAtherosclerosis, Cardiovascular Diseases, Female, Heart Disease Risk Factors, Humans, Male, Middle Aged, Obesity, Patient Acuity
Abstract

Background Research examining the role of obesity in cardiovascular disease (CVD) often fails to adequately consider heterogeneity in obesity severity, distribution, and duration. Methods and Results We here use multivariate latent class mixed models in the biracial Atherosclerosis Risk in Communities study (N=14 514; mean age=54 years; 55% female) to associate obesity subclasses (derived from body mass index, waist circumference, self-reported weight at age 25, tricep skinfold, and calf circumference across up to four triennial visits) with total mortality, incident CVD, and CVD risk factors. We identified four obesity subclasses, summarized by their body mass index and waist circumference slope as decline (4.1%), stable/slow decline (67.8%), moderate increase (24.6%), and rapid increase (3.6%) subclasses. Compared with participants in the stable/slow decline subclass, the decline subclass was associated with elevated mortality (hazard ratio [HR] 1.45, 95% CI 1.31, 1.60,

DOI10.1161/JAHA.121.019946
Alternate JournalJ Am Heart Assoc
PubMed ID34889111
PubMed Central IDPMC9075238
Grant ListR01 HL143885 / HL / NHLBI NIH HHS / United States
T32 HL129982 / HL / NHLBI NIH HHS / United States
HHSN268201700002I / HL / NHLBI NIH HHS / United States
HHSN268201700004I / HL / NHLBI NIH HHS / United States
HHSN268201700005I / HL / NHLBI NIH HHS / United States
HHSN268201700003I / HL / NHLBI NIH HHS / United States
KL2 TR002490 / TR / NCATS NIH HHS / United States
HHSN268201700004C / HL / NHLBI NIH HHS / United States
R01 HL149683 / HL / NHLBI NIH HHS / United States
R01 HG009974 / HG / NHGRI NIH HHS / United States
HHSN268201700001I / HL / NHLBI NIH HHS / United States
P2C HD050924 / HD / NICHD NIH HHS / United States
R01 HL146907 / HL / NHLBI NIH HHS / United States
U01 CA164975 / CA / NCI NIH HHS / United States